The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sandrock Alfred since 2013.
This trader's CIK number is 1577061.
At the time of last reporting, Sandrock Alfred was the President and CEO of Voyager Therapeutics, Inc.. (stock ticker symbol VYGR).
Also see all insider trading activities at Voyager Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | BIIB | 0 | $0 | 0 | $0 | 4,454 | $0 |
| 2020 | BIIB | 0 | $0 | 1,500 | $525,000 | 6,429 | $0 |
| 2019 | BIIB | 0 | $0 | 0 | $0 | 5,961 | $0 |
| 2018 | BIIB | 0 | $0 | 3,204 | $945,434 | 5,453 | $0 |
| 2017 | BIIB | 0 | $0 | 2,954 | $825,190 | 4,785 | $0 |
| 2016 | BIIB | 0 | $0 | 852 | $210,052 | 1,278 | $0 |
| 2015 | BIIB | 0 | $0 | 6,462 | $2,564,465 | 4,706 | $0 |
| 2014 | BIIB | 0 | $0 | 6,744 | $2,252,438 | 5,089 | $0 |
| 2013 | BIIB | 0 | $0 | 25,289 | $6,242,454 | 24,850 | $1,397,779 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VYGR | 0 | $0 | 39,231 | $161,016 | 0 | $0 |
| 2024 | VYGR | 0 | $0 | 25,148 | $216,679 | 0 | $0 |
| 2023 | VYGR | 0 | $0 | 7,437 | $58,231 | 0 | $0 |
2. Voyager Therapeutics, Inc. (VYGR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-12 | BIIB | Option Ex | 4,454 | .00 | 0 |
| 2020-11-04 | BIIB | Sale | 1,500 | 350.00 | 525,000 |
| 2020-02-15 | BIIB | Option Ex | 1,213 | .00 | 0 |
| 2020-02-12 | BIIB | Option Ex | 5,216 | .00 | 0 |
| 2019-02-15 | BIIB | Option Ex | 1,318 | .00 | 0 |
| 2019-02-12 | BIIB | Option Ex | 4,643 | .00 | 0 |
| 2018-02-27 | BIIB | Sale | 259 | 290.83 | 75,324 |
| 2018-02-23 | BIIB | Option Ex | 467 | .00 | 0 |
| 2018-02-23 | BIIB | Sale | 908 | 293.44 | 266,443 |
| 2018-02-22 | BIIB | Option Ex | 1,635 | .00 | 0 |
| 2018-02-20 | BIIB | Sale | 743 | 292.00 | 216,956 |
| 2018-02-15 | BIIB | Sale | 1,294 | 298.85 | 386,711 |
| 2018-02-15 | BIIB | Option Ex | 1,339 | .00 | 0 |
| 2018-02-12 | BIIB | Option Ex | 2,012 | .00 | 0 |
| 2017-04-03 | BIIB | Sale | 1,981 | 274.08 | 542,952 |
| 2017-03-01 | BIIB | Sale | 973 | 290.07 | 282,238 |
| 2017-02-28 | BIIB | Option Ex | 4,785 | .00 | 0 |
| 2016-02-08 | BIIB | Option Ex | 1,278 | .00 | 0 |
| 2016-02-09 | BIIB | Sale | 852 | 246.54 | 210,052 |
| 2015-12-04 | BIIB | Sale | 441 | 277.00 | 122,157 |
| 2015-03-27 | BIIB | Sale | 430 | 430.12 | 184,951 |
| 2015-03-02 | BIIB | Sale | 3,174 | 409.06 | 1,298,350 |
| 2015-02-17 | BIIB | Sale | 418 | 389.11 | 162,647 |
| 2015-02-12 | BIIB | Option Ex | 1,605 | .00 | 0 |
| 2015-02-10 | BIIB | Sale | 1,143 | 398.63 | 455,630 |
| 2015-02-08 | BIIB | Option Ex | 1,277 | .00 | 0 |
| 2015-02-09 | BIIB | Option Ex | 1,824 | .00 | 0 |
| 2015-02-09 | BIIB | Sale | 856 | 398.05 | 340,730 |
| 2014-12-04 | BIIB | Sale | 440 | 345.88 | 152,187 |
| 2014-03-04 | BIIB | Sale | 3,171 | 342.58 | 1,086,321 |
| 2014-02-26 | BIIB | Sale | 1,048 | 342.17 | 358,594 |
| 2014-02-23 | BIIB | Option Ex | 1,988 | .00 | 0 |
| 2014-02-11 | BIIB | Sale | 2,085 | 314.31 | 655,336 |
| 2014-02-09 | BIIB | Option Ex | 1,824 | .00 | 0 |
| 2014-02-08 | BIIB | Option Ex | 1,277 | .00 | 0 |
| 2013-12-04 | BIIB | Sale | 439 | 285.90 | 125,510 |
| 2013-10-22 | BIIB | Option Ex | 15,030 | 60.56 | 910,216 |
| 2013-10-22 | BIIB | Sale | 15,030 | 250.11 | 3,759,123 |
| 2013-09-16 | BIIB | Option Ex | 9,820 | 49.65 | 487,563 |
| 2013-09-16 | BIIB | Sale | 9,820 | 240.10 | 2,357,821 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-02 | VYGR | Sale | 10,885 | 3.43 | 37,335 |
| 2025-02-20 | VYGR | Sale | 11,702 | 4.24 | 49,616 |
| 2025-02-11 | VYGR | Sale | 16,644 | 4.45 | 74,065 |
| 2024-04-02 | VYGR | Sale | 12,115 | 9.86 | 119,453 |
| 2024-02-21 | VYGR | Sale | 13,033 | 7.46 | 97,226 |
| 2023-04-03 | VYGR | Sale | 7,437 | 7.83 | 58,231 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sandrock Alfred (President and CEO of Voyager Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.